07:52 AM EDT, 03/20/2024 (MT Newswires) -- Numinus Wellness Inc. ( NUMIF ) , a mental health care company, on Wednesday announced that it has submitted a Clinical Trial Application to Health Canada to assess the feasibility of a group model in MDMA-assisted psychotherapy enrolling trainee practitioners as participants. If approved, it will be the first of its kind.

The trial would allow Numinus to study MDMA-assisted psychotherapy with groups and better understand the optimum number of therapists required to deliver the programs safely. It may also provide eligible trainees with the opportunity to build core competencies and legally experience MDMA.